Reports
Sale
Global Vaccine Vials Market Size, Share, Trends, Forecast: By Type: Single Dose, Multiple Dose; By Material: Glass, Polymer; By Capacity: 10 ml, 20 ml, 5 ml, 3ml, 2ml; By Application: Preventive Vaccine, Therapeutics Vaccine; Regional Analysis; Market Dynamics: Market Drivers and Constraints; Supplier Landscape; 2024-2032
Global Vaccine Vials Market Outlook
The global vaccine vials market size was valued at USD 22.56 billion in 2023, driven by the rising research and development of vaccines across the globe. The market is expected to grow at a CAGR of 6.70% during the forecast period of 2024-2032, with the values likely to rise from USD 24.07 billion in 2024 to USD 40.44 billion by 2032.
Global Vaccine Vials Market Overview
Vaccines help to protect the body from various illnesses, particularly bacterial and viral infectious/non-infectious diseases. They are stored in cylindrical units called vaccine vials. The rise in infectious diseases has fuelled the production of vaccines. In 2023, around 64 infectious diseases were reported to affect individuals spanning across 235 countries. The surge in vaccine production to combat infectious diseases and other medical conditions has led to an increased vaccine vials market demand.
The increased investment in the research and development of vaccines is also bolstering the market growth for vaccine vials. In April 2023 , SK Bioscience, a vaccine development company based in South Korea, announced its plan to invest USD 1.8 billion in its vaccine and contract development and manufacturing organization (CDMO) businesses. They intend for strategic mergers and acquisitions initiatives in the vaccine domain, among others. With half of the investment reserved for vaccine development, the company plans to develop 5 more vaccine pipelines.
The vaccine vials market growth is also driven by the growing awareness among patients about immunization and its benefits. The rising healthcare expenditure to improve patient outcomes is another factor that will aid in the expansion of the market size.
Global Vaccine Vials Market Segmentation
Market Breakup by Type
- Single Dose
- Multiple Dose
The global vaccine vials market is segmented by type into single dose and multiple dose vials. Single dose vials are designed to contain a single dose of vaccine. It is commonly used for vaccines that require individual dosing or for vaccines with stability issues once opened. On the other hand, multiple dose vials are designed to contain multiple doses of vaccine.
Market Breakup by Material
- Glass
- Polymer
Based on the material, the market is divided into glass and polymer. Glass vials offer high transparency and compatibility with a wide range of pharmaceutical products. Polymer vials are cheaper and are often preferred for vaccines with less stringent storage requirements.
Market Breakup by Capacity
- 10 ml
- 20 ml
- 5 ml
- 3ml
- 2ml
The vaccine vials market share is segmented by capacity into various sizes, including 10 ml, 20 ml, 5 ml, 3 ml, and 2 ml vials. For higher doses or multiple administrations, larger capacities like 10 ml and 20 ml are preferred. For lower dosage requirements or individual doses, smaller capacities such as 5 ml, 3 ml, and 2 ml are considered ideal.
Market Breakup by Application
- Preventive Vaccine
- Therapeutics Vaccine
The market for vaccine vials is categorized by application into preventive vaccines and therapeutic vaccines. This segmentation reflects the diverse applications of vaccine vials, catering to different healthcare settings and needs.
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The market report offers deep insights into major regional markets such as North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is expected to led the market share, owing to the presence of multiple pioneering pharmaceutical and biotechnology companies, research facilities, and a robust healthcare infrastructure. With prominent academic institutions, Europe is also anticipated to hold a significant market size in the forecast period.
Global Vaccine Vials Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cardinal Health Inc.
- Nipro Corporation
- Thermo Fisher Scientific Inc.
- Zebra Technologies Corporation,
- Schott AG,
- Gerresheimer AG
- Lisaline Lifescience Technologies Pvt Ltd.
- DWK Life Sciences GmbH
- Catalent, Inc.,
- EVIGENCE SENSORS Inc.,
- Richland Glass Company Inc.
- Vetter Pharma
- Pacific Vial Manufacturing Inc.,
- Berlin Material Type LLC
- Stevanato Group
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Material |
|
| Breakup by Capacity |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Key Queries Solved in the Global Vaccine Vials Market Report
- How will the market landscape evolve in the coming years?
- What are the key market trends influencing the market?
- What are the major drivers, opportunities, and restraints in the market?
- Which country is poised to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What types of vaccine vials are available in the market?
- Which vaccine vial material is expected to dominate the respective market segment?
- Which key market players are projected to influence the market?
- What are the key research initiatives expected to boost the vaccine vials market share during the forecast period?
- What technological advancements and innovations are influencing vaccine vial design, materials, and manufacturing processes?
- Which segment has the most major impact on the market size?
- How did the COVID-19 pandemic affected the vaccine vials market?
- How are partnerships, collaborations, and mergers & acquisitions shaping the market dynamics?
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Vaccine Vials Market Overview
3.1 Global Vaccine Vials Market Historical Value (2017-2023)
3.2 Global Vaccine Vials Market Forecast Value (2024-2032)
4 Global Vaccine Vials Market Landscape*
4.1 Global Cardiac Pacemaker: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cardiac Pacemaker: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Material
4.2.3 Analysis by Capacity
4.2.4 Analysis by Application
5 Global Vaccine Vials Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Vaccine Vials Market Segmentation (2017-2032)
6.1 Global Vaccine Vials Market (2017-2032) by Type
6.1.1 Market Overview
6.1.2 Single Dose
6.1.3 Multiple Dose
6.2 Global Vaccine Vials Market (2017-2032) by Material
6.2.1 Market Overview
6.2.2 Glass
6.2.3 Polymer
6.3 Others Global Vaccine Vials Market (2017-2032) by Capacity
6.3.1 Market Overview
6.3.2 10 ml
6.3.3 20 ml
6.3.4 5 ml
6.3.5 3ml
6.3.6 2ml
6.4 Global Vaccine Vials Market (2017-2032) by Application
6.4.1 Market Overview
6.4.2 Preventive Vaccine
6.4.3 Therapeutics Vaccine
6.5 Global Vaccine Vials Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Sterility testing market (2017-2032)
7.1 North America Sterility testing market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Single Dose
7.1.3 Multiple Dose
7.2 North America Sterility testing market (2017-2032) by Material
7.2.1 Market Overview
7.2.2 Glass
7.2.3 Polymer
7.3 North America Sterility testing market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Sterility testing market (2017-2032)
8.1 Europe Sterility testing market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Single Dose
8.1.3 Multiple Dose
8.2 Europe Sterility testing market (2017-2032) by Material
8.2.1 Market Overview
8.2.2 Glass
8.2.3 Polymer
8.3 Europe Sterility testing market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Sterility testing market (2017-2032)
9.1 Asia Pacific Sterility testing market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Single Dose
9.1.3 Multiple Dose
9.2 Asia Pacific Sterility testing market (2017-2032) by Material
9.2.1 Market Overview
9.2.2 Glass
9.2.3 Polymer
9.3 Asia Pacific Sterility testing market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Sterility testing market (2017-2032)
10.1 Latin America Sterility testing market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Single Dose
10.1.3 Multiple Dose
10.2 Latin America Sterility testing market (2017-2032) by Material
10.2.1 Market Overview
10.2.2 Glass
10.2.3 Polymer
10.3 Latin America Sterility testing market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Sterility testing market (2017-2032)
11.1 Middle East and Africa Sterility testing market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Single Dose
11.1.3 Multiple Dose
11.2 Middle East and Africa Sterility testing market (2017-2032) by Material
11.2.1 Market Overview
11.2.2 Glass
11.2.3 Polymer
11.3 Middle East and Africa Sterility testing market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Type
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Cardinal Health Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Nipro Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Thermo Fisher Scientific Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Zebra Technologies Corporation,
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Schott AG,
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Gerresheimer AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Lisaline Lifescience Technologies Pvt Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 DWK Life Sciences GmbH
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Catalent, Inc.,
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 EVIGENCE SENSORS Inc.,
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Richland Glass Company Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Vetter Pharma
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Pacific Vial Manufacturing Inc.,
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Berlin Material Type LLC
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Stevanato Group,
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
List not exhaustive!
18 Global Vaccine Vials Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 22.56 billion in 2023 driven by the rising research and development of vaccines across the globe.
The market is anticipated to grow at a CAGR of 6.70% during the forecast period of 2024-2032, likely to reach a market value of USD 40.44 billion by 2032.
The rise in the prevalence of infectious diseases and the increased healthcare expenditure are fuelling the demand for vaccine vials.
One of the significant trends in the market is the increased investment in the research and development of vaccines by the key market players, which is positively impacting the market growth for vaccine vials.
Based on the type, the market is segmented by type into single dose and multiple dose vials.
Based on the material, the market is divided into glass and polymer.
The market is segmented by capacity into various sizes, including 10 ml, 20 ml, 5 ml, 3 ml, and 2 ml vials.
The market for vaccine vials is categorized by application into preventive vaccines and therapeutic vaccines.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Key players involved in the market are Cardinal Health Inc., Nipro Corporation, Thermo Fisher Scientific Inc., Zebra Technologies Corporation, Schott AG, Gerresheimer AG, Lisaline Lifescience Technologies Pvt Ltd., DWK Life Sciences GmbH, Catalent, Inc., EVIGENCE SENSORS Inc., Richland Glass Company Inc., Vetter Pharma, Pacific Vial Manufacturing Inc., Berlin Material Type LLC, and Stevanato Group.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER